Cargando…

Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis

BACKGROUND: Glycopyrronium tosylate (GT; Qbrexza(®) [glycopyrronium] cloth, 2.4%) is a topical anticholinergic approved (USA) for primary axillary hyperhidrosis in patients aged ≥ 9 years. OBJECTIVE: The objective of this study was to compare the pharmacokinetics and safety of GT to oral glycopyrrol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pariser, David M., Lain, Edward L., Mamelok, Richard D., Drew, Janice, Mould, Diane R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113176/ https://www.ncbi.nlm.nih.gov/pubmed/33433785 http://dx.doi.org/10.1007/s40262-020-00975-y

Ejemplares similares

A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis
por: Glaser, Dee Anna, et al.
Publicado: (2019)

Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use
por: Lamb, Yvette N.
Publicado: (2019)

Correction to: Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use
por: Lamb, Yvette N.
Publicado: (2019)

Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials
por: Pariser, David M., et al.
Publicado: (2018)

Long‐term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44‐week open‐label extension study
por: Hebert, Adelaide A., et al.
Publicado: (2020)

Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials
por: Hebert, Adelaide A., et al.
Publicado: (2018)

Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: A randomized, double‐blind, vehicle‐controlled study
por: Yokozeki, Hiroo, et al.
Publicado: (2021)

Therapeutic treatment of multiple eccrine hidrocystomas with topical glycopyrronium tosylate 2.4% solution
por: Olamiju, Brianna, et al.
Publicado: (2020)

A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial
por: Abels, C., et al.
Publicado: (2021)

A Prospective, Nonrandomized, Open‐Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis
por: Glaser, Dee Anna, et al.
Publicado: (2015)

Questionnaire-based epidemiological survey of primary focal hyperhidrosis and survey on current medical management of primary axillary hyperhidrosis in Japan
por: Fujimoto, Tomoko, et al.
Publicado: (2022)

Effects of Direct Current Administration on Hyperhidrosis Disease Severity Scale in Patients with Axillary Hyperhidrosis
por: Şener, Serpil, et al.
Publicado: (2019)

Cost‐of‐illness study for axillary hyperhidrosis in Japan
por: Murota, Hiroyuki, et al.
Publicado: (2021)

A retrospective cohort study of T3 versus T4 thoracoscopic sympathectomy for primary palmar hyperhidrosis and primary palmar hyperhidrosis with axillary and plantar sweating
por: Xie, Hongya, et al.
Publicado: (2019)

A novel option for treatment of primary axillary hyperhidrosis: Fractionated microneedle radiofrequency
por: Naeini, F Fatemi, et al.
Publicado: (2015)

Single incision thoracoscopic sympathectomy for palmar and axillary hyperhidrosis
por: Baram, Aram
Publicado: (2014)

Thoracic sympathectomy for the treatment of primary axillary hyperhidrosis: systematic review and proportional meta-analysis
por: Felisberto, Gilmar, et al.
Publicado: (2021)

Clinical Evaluation of a Microwave Device for Treating Axillary Hyperhidrosis
por: Hong, H Chih-Ho, et al.
Publicado: (2012)

Surgical treatment of axillary hyperhidrosis by suction-curettage of sweat glands
por: de Rezende, Rebeca Maffra, et al.
Publicado: (2014)

Aquagenic palmoplantar keratoderma therapeutic response to topical glycopyrronium
por: Medhus, Emily J., et al.
Publicado: (2021)

Quality of life in patients with primary axillary hyperhidrosis before and after treatment with fractionated microneedle radiofrequency
por: Abtahi-Naeini, Bahareh, et al.
Publicado: (2015)

Thoracoscopic bilateral dorsal sympathectomy for primary palmo-axillary hyperhidrosis short- and mid-term results
por: Puri, Harsh Vardhan, et al.
Publicado: (2021)

Machine learning analysis of primary hyperhidrosis for classification of hyperhidrosis type and prediction of compensatory hyperhidrosis
por: Hyun, Kwan Yong, et al.
Publicado: (2023)

Comparison of the efficacy of ETS with different segments for palmar, axillary and plantar hyperhidrosis
por: Hong, Ziqiang, et al.
Publicado: (2023)

Topical Glycopirrolate for the Management of Hyperhidrosis in Herpetic Neuralgia
por: Ladjevic, Nebojsa Gojko, et al.
Publicado: (2009)

Anatomical variation of sympathetic ganglia in R4+R5 sympathicotomy for primary palmar axillary hyperhidrosis
por: Weng, Wenhan, et al.
Publicado: (2023)

Thoracoscopic sympathetic block to predict compensatory hyperhidrosis in primary hyperhidrosis
por: Lee, June, et al.
Publicado: (2021)

New sympathicotomy for prevention of severe compensatory hyperhidrosis in patients with primary hyperhidrosis
por: Han, Jung Wook, et al.
Publicado: (2020)

Treatment of Primary Axillary Hyperhidrosis by Fractional Microneedle Radiofrequency: Is it Still Effective after Long-term Follow-up?
por: Abtahi-Naeini, Bahareh, et al.
Publicado: (2016)

Two‐week prospective observational study of 5% sofpironium bromide gel in Japanese patients with primary axillary hyperhidrosis
por: Fujimoto, Tomoko, et al.
Publicado: (2022)

The Effect of Thoracoscopic Sympathicotomy at the Fourth Rib (R4) for the Treatment of Palmar and Axillary Hyperhidrosis
por: Kim, Jae-Bum, et al.
Publicado: (2011)

Impact of microwave thermolysis energy levels on patient‐reported outcomes for axillary hyperhidrosis and osmidrosis
por: Grove, G. L., et al.
Publicado: (2022)

Sympathetic Nerve Reconstruction for Compensatory Hyperhidrosis after Sympathetic Surgery for Primary Hyperhidrosis
por: Haam, Seok Jin, et al.
Publicado: (2010)

Treatment of Primary Axillary Hyperhidrosis with Botulinum Toxin Type A: Our Experience in 50 Patients from 2007 to 2010
por: Scamoni, Stefano, et al.
Publicado: (2012)

Hyperhidrosis: A Review of Recent Advances in Treatment with Topical Anticholinergics
por: Wong, Nikita S., et al.
Publicado: (2022)

Thoracoscopic sympathicotomy for the treatment of intolerable palmar and axillary hyperhidrosis in children is associated with high recurrence rates
por: Verhaegh, Arjan J. F. P., et al.
Publicado: (2020)

Treatment of Alcohols with Tosyl Chloride Does Not always Lead to the Formation of Tosylates
por: Ding, Rui, et al.
Publicado: (2011)

Efficacy of Glycopyrrolate in Primary Hyperhidrosis Patients
por: Lee, Hyun Ho, et al.
Publicado: (2012)

Anxiety after Sympathectomy in patients with primary palmar hyperhidrosis may prolong the duration of compensatory hyperhidrosis
por: Qian, Kai, et al.
Publicado: (2018)

Topical Oxybutynin 3% Gel Versus Aluminum Chloride 15% Lotion in Treatment of Primary Focal Hyperhidrosis
por: El-Agamy El-Samadony, Amany, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_10buqr03j2c8pp6js1fbo1fjbl